Form D/A — GelMEDIX, Inc.
0001815624-26-000001 · filed Jan 8, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $542,000
- Reported amount sold
- $542,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- GelMEDIX, Inc.
- CIK
- 1815624
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 238 MAIN STREET, FIFTH FLOOR
CAMBRIDGE, Massachusetts 02142 - Phone
- 941-228-8711
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Max Cotler · Executive OfficerCambridge, Massachusetts Find on LinkedIn ↗
-
Nasim Annabi · DirectorCambridge, Massachusetts Find on LinkedIn ↗
-
Reza Dana · DirectorCambridge, Massachusetts Find on LinkedIn ↗
-
Michael Cima · DirectorCambridge, Massachusetts Find on LinkedIn ↗
-
Parinaz Motamedy · DirectorCambridge, Massachusetts Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗